Autolus Therapeutics PLC (NAS:AUTL)
$ 3.92 0.05 (1.29%) Market Cap: 1.04 Bil Enterprise Value: 335.67 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Q1 2019 Autolus Therapeutics PLC Earnings Call Transcript

May 14, 2019 / 12:30PM GMT
Release Date Price: $23.84 (+6.48%)
Operator

Good day, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to introduce your host for today's conference, Silvia Taylor, Vice President of Corporate Affairs and Communication. Ma'am, please proceed.

Silvia Taylor
Autolus Therapeutics plc - VP of Corporate Affairs & Communications

Thank you, Lauren. Good morning, and good afternoon, everyone. Thank you for taking part in today's call. With me today, I have Dr. Christian Itin, Chairman and Chief Executive Officer; and Andrew Oakley, Chief Financial Officer. Also, Christopher Vann, Chief Operating Officer, will join us for the Q&A portion of our call.

Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements, other than statements of historical fact contained in this presentation are forward-looking statements. Our actual results, performance or achievements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot